Randall Espinoza, MD, MPH

Faculty Appointment(s)

Professor of Psychiatry and Behavioral Sciences, University of Washington

Garvey Family Endowed Professor for Technology and Brain Health

Emeritus Professor of Clinical Psychiatry, Geffen School of Medicine at UCLA, University of California, Los Angeles

Leadership Role(s)

Medical Director, Garvey Institute Center for Neuromodulation

respinoz@uw.edu

I am currently the Medical Director at the Garvey Institute Center for Neuromodulation and am providing leadership to help grow our portfolio in the area of Neuromodulation and Interventional Psychiatry. Before coming to the UW, I was the Muriel Harris Chair of Geriatric Psychiatry and Professor of Clinical Psychiatry at UCLA. While at UCLA, I held many administrative, clinical and teaching leadership positions including serving as Medical Director of Inpatient Geriatric Psychiatry, Chief of Staff of the UCLA Neuropsychiatric Hospital, Founding Faculty of the UCLA Neuromodulation Division, Medical Director of the ECT and Interventional Psychiatry Program, among others.

I recently became Editor-in-Chief of the Journal of ECT and Related Therapies, the official publication of the International Society of ECT and Neurostimulation. My research projects have included investigating various neuromodulation and interventional therapies and developing novel educational programs and curricula. I have an abiding interest in mentoring and helping faculty at the start of their careers and a commitment to fostering the advancement of women and underrepresented minority (URM) faculty in academic medicine.

Education

MPH, UCLA School of Public Health (Executive Health Services), Los Angeles, CA, 2002
Geriatric Psychiatry Fellow, UCLA Geriatric Psychiatry Fellowship Program, Los Angeles, CA, 1996
MD, University of Texas Southwestern Medical School, Dallas, TX, 1990

Department Affiliations

Centers/Programs

Other Affiliations

Editor in Chief, Journal of ECT and Related Therapies (2024-present)
American College of Psychiatrists

Recent Publications

Editor's Roundup: Known Knowns, Known Unknowns, and Unknown Unknowns in ECT--Due Diligence and Preparation Are Sine Qua Nons of Practice; Machine Learning to Refine and Inform ECT Practice; the CARE Network Helps Drive Better Understanding of Treatment Variation to Improve Outcomes, Practice, Education, and Policy, Among Other Uses; Advocacy for ECT in Guidelines and in the Arts-A Reminder of Our Role.
(2024 Dec 1)
J ECT 40(4): 221-222
Espinoza RT
Electroconvulsive therapy and cognitive performance from the Global ECT MRI Research Collaboration.
(2024 Nov)
J Psychiatr Res 179(): 199-208
Kiebs M, Farrar DC, Yrondi A, Cardoner N, Tuovinen N, Redlich R, Dannlowski U, Soriano-Mas C, Dols A, Takamiya A, Tendolkar I, Narr KL, Espinoza R, Laroy M, van Eijndhoven P, Verwijk E, van Waarde J, Verdijk J, Maier HB, Nordanskog P, van Wingen G, van Diermen L, Emsell L, Bouckaert F, Repple J, Camprodon JA, Wade BSC, Donaldson KT, Oltedal L, Kessler U, Hammar Å, Sienaert P, Hebbrecht K, Urretavizcaya M, Belge JB, Argyelan M, Baradits M, Obbels J, Draganski B, Philipsen A, Sartorius A, Rhebergen D, Ousdal OT, Hurlemann R, McClintock S, Erhardt EB, Abbott CC
Editor's Roundup: ECT for Pediatric Depression and Catatonia - It Works and Is Safe; Maintenance Strategies and Impact on Long-Term Outcomes; and What to Do About Glucagon-Like Peptide-1 Receptor Agonists and ECT.
(2024 Sep 1)
J ECT 40(3): 143-144
Espinoza RT
Author Reply to Letter to the Editor.
(2024 Sep 1)
J ECT 40(3): 220
Antongiorgi Z, Espinoza R
Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression.
(2024 Jun)
Brain Behav 14(6): e3511
Taraku B, Loureiro JR, Sahib AK, Zavaliangos-Petropulu A, Al-Sharif N, Leaver AM, Wade B, Joshi S, Woods RP, Espinoza R, Narr KL
Show complete publication list »
Edit Profile